solution stability, DNA binding, Cytotoxicity, structure-property relationship, topoisomerase inhibition
Anticancer, Ru(II) complexes, X-ray crystal structures, Cytotoxicity, DNA binding, Fluorescence lifetime
solution stability, aminoguanidine, EPR spectroscopy, cyclic voltammetry, Copper complexes, x-ray crystallography
Anticancer drugs, Indolo[2, 3-c]quinolines, Schiff bases, Copper(II) complexes, Antiproliferative activity, DNA intercalation, ROS generation, mitochondrial dysfunction, LDH release, Apoptosis
Iron-cyclopentadienyl, ABCB1 inhibitor, cancer multidrug resistance, colon adenocarcinoma
Copper(II) complexes, Cancer, Hypoxia, ROS, speciation, Biomimetic